Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2020 Issue has been successfully launched on 1 November 2020

Abstract

DOWNREGULATION OF NAD(P)H: QUINONE OXIDOREDUCTASE INHIBITS MULTIPLICATION, CELL CYCLE AND MOVEMENT OF CHOLANGIOCARCINOMA CELLS

Abhijeet B. Bhole*, Rutuja S. Gunjal and Survana M. Gunjal

ABSTRACT

We recently detailed that upregulation of NAD(P) H:quinone oxidoreductase 1 (NQO1) in cholangiocarcinoma (CCA; a lethal bile conduit disease) was related with helpless guess. It was additionally shown that the concealment of NQO1 had the option to improve the chemosensitivity of CCA cells. In the current investigation, so as to explain the organic part of NQO1 in CCA, the impacts of little meddling RNA (siRNA)- intervened knockdown of NQO1 on cell expansion, cell cycle and movement were resolved in KKU-100 CCA cells, which quite communicated NQO1. The cell expansion capacity and cell cycle conveyance were recognized by clonogenic cell endurance test and stream cytometric investigation, individually. Wound recuperating and Transwell movement measures were performed to assess cell movement. The particles engaged with cell expansion and movement were resolved by western smear investigation and converse record quantitative polymerase chain response examination. The outcomes illustrated that NQO1 siRNA-intervened knockdown adequately disabled settlement development limit, actuated cell cycle capture at the G1 stage and stifled movement of KKU-100 cells. CCA cells transfected with NQO1 siRNA displayed expanded articulation levels of p21 and diminished cyclin D1 protein articulation levels. Moreover, the proportion of grid metalloproteinase 9/tissue inhibitors of metalloproteinases 1 (TIMP1) mRNA articulation level was diminished in the NQO1-knockdown cells. In this manner, the current investigation gave proof supporting the organic part of NQO1 in the guideline of cell expansion, cell cycle what's more, relocation of CCA cells. Accordingly, NQO1 may end up being a likely sub-atomic objective to improve CCA treatment.

Keywords: NQO1, polymerase, oxidoreductase, cell proliferation, cholangiocarcinoma.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More